FluroTech Wins Best of Show for New Technology by High! Canada Magazine at the Vancouver Lift Expo
FluroTech (TSXV:TEST) (OTCQB: FLURF), (“FluroTech” or the “Company”) is pleased to announce that the CompleTest was selected as the best of show for new cannabis technology by High! Canada Magazine at the recent Vancouver LIFT Expo.
“The award was unexpected,” commented Gary Jones, VP Business Development at FluroTech. “The Vancouver LIFT Expo was the first time FluroTech unveiled the CompleTest to the public. Master growers and quality assurance personnel were impressed by the live demonstrations, which reaffirmed the confidence the Company has in the technology. Feedback was positive with respect to the simplicity, speed, accuracy, and consistency of results of the product. Master growers recognized that they could affordably and accurately use the in-house testing device to select mother plants for breeding or to optimize their potency yield for a given strain.”
The Company believes that a fast, reliable, accurate and easy-to-use in-house testing device is required in the cannabis industry so that growers can focus on precision agriculture and optimize the potency yield of their crop, without waiting for outside quality assurance personnel or third-party lab results. Moreover, licensed producers will have data at their fingertips to ensure third-party labs are providing accurate and consistent results.
The Company has launched sales of CompleTestTM and is focusing its sales efforts in Western Canada.
CompleTest is FluroTech’s flagship brand and product line. CompleTest is a portable, cost-effective, state-of-the-art cannabis testing device, able to provide fast, accurate and consistent testing results. It is designed for cultivators, dispensaries and anyone with an interest in precision agriculture to optimize potency yield and consumer safety to test the quality and safety of their cannabis products.
FluroTech is a technology and marketing company whose core business is focused on the commercialization of new technologies in the cannabis industry. FluroTech’s proprietary spectroscopy-based technology allows for the testing and identification of organic and inorganic compounds contained within biological samples. Using the technology that was developed at the University of Calgary, FluroTechhas developed a two-part solution comprising an instrument called the CompleTest and consumable testing kits.
To learn more, visit www.FluroTech.com.
VP Business Development
Chief Executive Officer
Alistair Ross Technology Centre
Suite 111, 3553-31 Street NW
Calgary, AB T2L 2K7
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities. The securities described herein have not been and will not be registered under the United States Securities Act of 1933, as amended, or the securities laws of any state and may not be offered or sold within the United States or to or for the benefit or account of U.S. persons, absent such registration or an applicable exemption from such registration requirements.
Cautionary Statement Regarding Forward-Looking Information
This news release contains “forward-looking information” within the meaning of Canadian securities legislation. Forward-looking information generally refers to information about an issuer’s business, capital, or operations that is prospective in nature, and includes future-oriented financial information about the issuer’s prospective financial performance or financial position. The forward-looking information in this news release includes disclosure about the benefits of the Company’s CompleTest testing device.
The Company made certain material assumptions, including but not limited to prevailing market conditions and general business, economic, competitive, political and social uncertainties to develop the forward-looking information in this news release. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.
Actual results may vary from the forward-looking information in this news release due to certain material risk factors. These risk factors include, but are not limited to, adverse market conditions and regulatory and other risks associated with the cannabis industry in general, and users of the CompleTest failing to achieve the anticipated benefits of the product. The Company cautions that the foregoing list of material risk factors and assumptions is not exhaustive.
The Company assumes no obligation to update or revise the forward-looking information in this news release, unless it is required to do so under Canadian securities legislation.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy of this release.